Irma M. Verdonck‐de Leeuw
Amsterdam Neuroscience, Amsterdam University Medical Centers
Papers
2
Total Citations
38
H-Index
2
About
Irma M. Verdonck‐de Leeuw is a leading researcher in head and neck oncology and surgical outcomes, with a particular focus on quality of life (QoL) and functional recovery. Her work bridges the gap between surgical innovation and patient-centered care, notably through her involvement in the LEOPARD randomized trial, which demonstrated that minimally invasive distal pancreatectomy (MIDP) significantly improves short-term QoL and time to functional recovery compared to open surgery—a finding with over 35 citations that has influenced surgical practice. She has also advanced the understanding of swallowing outcomes in head and neck cancer, particularly in patients with unknown primary tumors, where her research on transoral robotic surgery and adjuvant treatment has provided critical insights into optimizing functional recovery. Her contributions extend to evaluating long-term QoL and cosmetic satisfaction, underscoring the importance of patient-reported outcomes in surgical decision-making. With a career marked by high-impact studies that integrate clinical rigor with real-world patient experiences, Verdonck‐de Leeuw remains a pivotal figure in shaping evidence-based, patient-focused surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2